Invention Grant
US08853156B2 Treatment for diabetes in patients inappropriate for metformin therapy
有权
治疗不适合二甲双胍治疗的患者的糖尿病
- Patent Title: Treatment for diabetes in patients inappropriate for metformin therapy
- Patent Title (中): 治疗不适合二甲双胍治疗的患者的糖尿病
-
Application No.: US13057295Application Date: 2009-08-05
-
Publication No.: US08853156B2Publication Date: 2014-10-07
- Inventor: Klaus Dugi , Eva Ulrike Graefe-Mody , Ruth Harper , Hans-Juergen Woerle
- Applicant: Klaus Dugi , Eva Ulrike Graefe-Mody , Ruth Harper , Hans-Juergen Woerle
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; David L. Kershner
- Priority: EP08161989 20080807; EP08166827 20081016
- International Application: PCT/EP2009/060170 WO 20090805
- International Announcement: WO2010/015664 WO 20100211
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/28 ; A61P3/10 ; A61P7/12 ; C07K14/62 ; A01N43/58 ; A01N43/60 ; A61K31/50 ; A61K31/495 ; A61K31/52 ; A61K31/513 ; A61K31/4375 ; A61K31/4439 ; A61K31/427 ; A61K31/422 ; A61K31/403 ; A61K31/4025 ; A61K31/40 ; A61K31/506 ; A61K31/4985 ; A61K31/522 ; A61K31/5025
Abstract:
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin.
Public/Granted literature
- US20110263493A1 Treatment for diabetes in patients inappropriate for metformin therapy Public/Granted day:2011-10-27
Information query
IPC分类:
